The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
Exploration of the medical periodic table: towards new targets
Open accessAbstract
Metallodrugs offer potential for unique mechanisms of drug action based on the choice of the metal, its oxidation state, the types and number of coordinated ligands and the coordination geometry. We discuss recent progress in identifying new target sites and elucidating the mechanisms of action of anti-cancer, anti-bacterial, anti-viral, anti-parasitic, anti-inflammatory, and anti-neurodegenerative agents, as well as in the design of metal-based diagnostic agents. Progress in identifying and defining target sites has been accelerated recently by advances in proteomics, genomics and metal speciation analysis. Examples of metal compounds and chelating agents (enzyme inhibitors) currently in clinical use, clinical trials or preclinical development are highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Thermodynamic and kinetic data for macrocycle interactions with cations and anions
Izatt, R. M., Pawlak, K., Bradshaw, J. S., & Bruening, R. L. (1991) · Chemical Reviews · doi:10.1021/cr00008a003 · Cited by 1,945
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Rai, M. K., Deshmukh, S. D., Ingle, A. P., & Gade, A. K. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05253.x · Cited by 1,524
Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,265
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future
Arvizo, R. R., Bhattacharyya, S., Kudgus, R. A., Giri, K., Bhattacharya, R., & Mukherjee, P. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15355f · Cited by 866
Hartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
Inhibition of Cancer Cell Growth by Ruthenium(II) Arene Complexes
Morris, R. E., Aird, R. E., del Socorro Murdoch, P., Chen, H., Cummings, J., Hughes, N. D., Parsons, S., Parkin, A., Boyd, G., Jodrell, D. I., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010051m · Cited by 787
Self-citationMetal-based antitumour drugs in the post genomic era
Dyson, P. J., & Sava, G. (2006) · Dalton Transactions · doi:10.1039/b601840h · Cited by 771
Takahara, P. M., Rosenzweig, A. C., Frederick, C. A., & Lippard, S. J. (1995) · Nature · doi:10.1038/377649a0 · Cited by 769
Metal Complexes as DNA Intercalators
Liu, H.-K., & Sadler, P. J. (2011) · Accounts of Chemical Research · doi:10.1021/ar100140e · Cited by 749
Self-citationBioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Areneruthenium complexes as anticancer agents
Süß‐Fink, G. (2009) · Dalton Transactions · doi:10.1039/b916860p · Cited by 652
Timerbaev, A. R., Hartinger, C. G., Aleksenko, S. S., & Keppler, B. K. (2006) · Chemical Reviews · doi:10.1021/cr040704h · Cited by 614
Characterization of the FKBP·Rapamycin·FRB Ternary Complex
Banaszynski, L. A., Liu, C. W., & Wandless, T. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja043277y · Cited by 609
Hickey, J. L., Ruhayel, R. A., Barnard, P. J., Baker, M. V., Berners-Price, S. J., & Filipovska, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja804027j · Cited by 599
Biological inorganic chemistry: structure and reactivity
(2007) · Choice Reviews Online · doi:10.5860/choice.44-6242 · Cited by 573
Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins
Ohndorf, U.-M., Rould, M. A., He, Q., Pabo, C. O., & Lippard, S. J. (1999) · Nature · doi:10.1038/21460 · Cited by 565
Anticancer Activity of Metal Complexes: Involvement of Redox Processes
Jungwirth, U., Kowol, C. R., Keppler, B. K., Hartinger, C. G., Berger, W., & Heffeter, P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3663 · Cited by 554
Dhar, S., Daniel, W. L., Giljohann, D. A., Mirkin, C. A., & Lippard, S. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9071282 · Cited by 510
Knox, R. J., Friedlos, F., Lydall, D. A., & Roberts, J. J. (1986) · PubMed · Cited by 498
Strained Ruthenium Complexes Are Potent Light-Activated Anticancer Agents
Howerton, B. S., Heidary, D. K., & Glazer, E. C. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3009677 · Cited by 498
Allardyce, C. S., Dyson, P. J., Ellis, D. J., & Heath, S. L. (2001) · Chemical Communications · doi:10.1039/b104021a · Cited by 495
Targeted α particle immunotherapy for myeloid leukemia
Jurcic, J. G., Larson, S. M., Sgouros, G., McDevitt, M. R., Finn, R. D., Divgi, C. R., Ballangrud, Å. M., Hamacher, K. A., Ma, D., Humm, J. L., et al. (2002) · Blood · doi:10.1182/blood.v100.4.1233.h81602001233_1233_1239 · Cited by 472
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA
Eastman, A. (1986) · Biochemistry · doi:10.1021/bi00361a026 · Cited by 458
Targeting proteins with metal complexes
Meggers, E. (2009) · Chemical Communications · doi:10.1039/b813568a · Cited by 450
Therrien, B., Süss‐Fink, G., Govindaswamy, P., Renfrew, A. K., & Dyson, P. J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800186 · Cited by 446
Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA
Pinto, A. L., & Lippard, S. J. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(85)90001-0 · Cited by 437
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
Hara, T., Miyazaki, J., Araki, H., Yamaoka, M., Kanzaki, N., Kusaka, M., & Miyamoto, M. (2003) · PubMed · Cited by 425
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
Faux, N. G., Ritchie, C. W., Gunn, A., Rembach, A., Tsatsanis, A., Bedo, J., Harrison, J., Lannfelt, L., Blennow, K., Zetterberg, H., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1390 · Cited by 405
The coordination chemistry of vanadium as related to its biological functions
Rehder, D. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(98)00194-5 · Cited by 376
Modifications of DNA by platinum complexes
Brabec, V., & Kasparkova, J. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.04.006 · Cited by 373
Clément, L., Hurel, C., & Marmier, N. (2013) · Chemosphere · doi:10.1016/j.chemosphere.2012.09.013 · Cited by 371
Designing organometallic compounds for catalysis and therapy
Noffke, A. L., Habtemariam, A., Pizarro, A. M., & Sadler, P. J. (2012) · Chemical Communications · doi:10.1039/c2cc30678f · Cited by 370
Self-citationOrganometallic Half-Sandwich Iridium Anticancer Complexes
Liu, Z., Habtemariam, A., Pizarro, A. M., Fletcher, S. A., Kisova, A., Vrana, O., Salassa, L., Bruijnincx, P. C. A., Clarkson, G. J., Brabec, V., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000932 · Cited by 357
Self-citationIntroduction: The History of Arsenic Trioxide in Cancer Therapy
Antman, K. H. (2001) · The Oncologist · doi:10.1634/theoncologist.6-suppl_2-1 · Cited by 355
Rawat, R., Whitty, A., & Tonge, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235848100 · Cited by 330
Bonomi, P. D., Finkelstein, D. M., Ruckdeschel, J. C., Blum, R. H., Green, M. D., Mason, B., Hahn, R., Tormey, D. C., Harris, J., & Comis, R. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.11.1602 · Cited by 323
Biocoordination chemistry of bismuth: Recent advances
YANG, N., & SUN, H. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.03.003 · Cited by 319
Therapeutic applications of carbon monoxide-releasing molecules
Motterlini, R., Mann, B. E., & Foresti, R. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.11.1305 · Cited by 315
Solution Structure of a Cisplatin-Induced DNA Interstrand Cross-Link
Huang, H., Zhu, L., Reid, B. R., Drobny, G. P., & Hopkins, P. B. (1995) · Science · doi:10.1126/science.270.5243.1842 · Cited by 314
A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
Debnath, A., Parsonage, D., Andrade, R. M., He, C., Cobo, E. R., Hirata, K., Chen, S., García-Rivera, G., Orozco, E., Martínez, M. B., et al. (2012) · Nature Medicine · doi:10.1038/nm.2758 · Cited by 306
Pierroz, V., Joshi, T., Leonidova, A., Mari, C., Schur, J., Ott, I., Spiccia, L., Ferrari, S., & Gasser, G. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307288s · Cited by 296
Organometallic Cages as Vehicles for Intracellular Release of Photosensitizers
Schmitt, F., Freudenreich, J., Barry, N. P. E., Juillerat-Jeanneret, L., Süss-Fink, G., & Therrien, B. (2012) · Journal of the American Chemical Society · doi:10.1021/ja207784t · Cited by 293
Self-citationRuthenium complexes can target determinants of tumour malignancy
Bergamo, A., & Sava, G. (2007) · Dalton Transactions · doi:10.1039/b617769g · Cited by 291
Gelasco, A., & Lippard, S. J. (1998) · Biochemistry · doi:10.1021/bi973176v · Cited by 282
Transport pathways for arsenic and selenium: A minireview
Rosen, B. P., & Liu, Z. (2009) · Environment International · doi:10.1016/j.envint.2008.07.023 · Cited by 280
Exploring biologically relevant chemical space with metal complexes
Meggers, E. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.013 · Cited by 274
Rosenblat, T. L., McDevitt, M. R., Mulford, D. A., Pandit-Taskar, N., Divgi, C. R., Panageas, K. S., Heaney, M. L., Chanel, S., Morgenstern, A., Sgouros, G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0382 · Cited by 271
Drug Development Based on the Metals Hypothesis of Alzheimer's Disease
Bush, A. I. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15208 · Cited by 267
Niesel, J., Pinto, A., Peindy N'Dongo, H. W., Merz, K., Ott, I., Gust, R., & Schatzschneider, U. (2008) · Chemical Communications · doi:10.1039/b719075a · Cited by 267
On the mechanism of the antitumor activity of ferrocenium derivatives
Osella, D., Ferrali, M., Zanello, P., Laschi, F., Fontani, M., Nervi, C., & Cavigiolio, G. (2000) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)00147-x · Cited by 266
Targeted and multifunctional arene ruthenium chemotherapeutics
Smith, G. S., & Therrien, B. (2011) · Dalton Transactions · doi:10.1039/c1dt11007a · Cited by 262
Metal Carbonyls: A New Class of Pharmaceuticals?
Johnson, T. R., Mann, B. E., Clark, J. E., Foresti, R., Green, C. J., & Motterlini, R. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200301634 · Cited by 261
Lactoferrin, a bird’s eye view
Vogel, H. J. (2012) · Biochemistry and Cell Biology · doi:10.1139/o2012-016 · Cited by 260
Metal-associated amyloid-β species in Alzheimer's disease
Pithadia, A. S., & Lim, M. H. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.01.016 · Cited by 259
The Composition of Ehrlich's Salvarsan: Resolution of a Century‐Old Debate
Lloyd, N. C., Morgan, H. W., Nicholson, B. K., & Ronimus, R. S. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461471 · Cited by 256
Wang, F., Chen, H., Parsons, S., Oswald, I. D. H., Davidson, J. E., & Sadler, P. J. (2003) · Chemistry – A European Journal · doi:10.1002/chem.200304724 · Cited by 254
Self-citationSchatzschneider, U. (2011) · Inorganica Chimica Acta · doi:10.1016/j.ica.2011.02.068 · Cited by 251
Harrison, M. L., Obermueller, E., Maisey, N. R., Hoare, S., Edmonds, K., Li, N. F., Chao, D., Hall, K., Lee, C., Timotheadou, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2136 · Cited by 251
Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
Nowak-Sliwinska, P., van Beijnum, J. R., Casini, A., Nazarov, A. A., Wagnières, G., van den Bergh, H., Dyson, P. J., & Griffioen, A. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2002074 · Cited by 248
Schuh, E., Pflüger, C., Citta, A., Folda, A., Rigobello, M. P., Bindoli, A., Casini, A., & Mohr, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300428v · Cited by 246
Photoactivatable Platinum Complexes
Bednarski, P. J., Mackay, F. S., & Sadler, P. J. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007779314053 · Cited by 244
Self-citationEnzyme inhibition by metal complexes: concepts, strategies and applications
Kilpin, K. J., & Dyson, P. J. (2013) · Chemical Science · doi:10.1039/c3sc22349c · Cited by 242
Lovejoy, K. S., Todd, R. C., Zhang, S., McCormick, M. S., D'Aquino, J. A., Reardon, J. T., Sancar, A., Giacomini, K. M., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803441105 · Cited by 238
Targeted delivery of platinum-based anticancer complexes
Butler, J. S., & Sadler, P. J. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.01.004 · Cited by 237
Self-citationInteractions between mammalian cell DNA and inorganic platinum compounds—I
Pascoe, J. M., & Roberts, J. J. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90354-2 · Cited by 236
Mustacich, D. J., & Powis, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460001 · Cited by 231
The Potentiality Of Vanadium In Medicinal Applications
Rehder, D. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.103 · Cited by 229
Yang, D., van Boom, S. S. G. E., Reedijk, J., van Boom, J. H., & Wang, A. H.-J. (1995) · Biochemistry · doi:10.1021/bi00039a054 · Cited by 225
Romero-Canelón, I., Salassa, L., & Sadler, P. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3017442 · Cited by 221
Self-citationChromium is not an essential trace element for mammals: effects of a “low-chromium” diet
Di Bona, K. R., Love, S., Rhodes, N. R., McAdory, D., Sinha, S. H., Kern, N., Kent, J., Strickland, J., Wilson, A., Beaird, J., et al. (2011) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-010-0734-y · Cited by 220
Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor Fusin/CXCR-4
Schols, D., Esté, J. A., Henson, G., & De Clercq, E. (1997) · Antiviral Research · doi:10.1016/s0166-3542(97)00025-9 · Cited by 220
Campbell, N. H., Karim, N. H. A., Parkinson, G. N., Gunaratnam, M., Petrucci, V., Todd, A. K., Vilar, R., & Neidle, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201140v · Cited by 220
Wild, D., Bomanji, J. B., Benkert, P., Maecke, H., Ell, P. J., Reubi, J. C., & Caplin, M. E. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.111724 · Cited by 218
Metal complex catalysis in living biological systems
Sasmal, P. K., Streu, C. N., & Meggers, E. (2013) · Chem. Commun. · doi:10.1039/c2cc37832a · Cited by 217
New anti‐HIV agents and targets
Clercq, E. D. (2002) · Medicinal Research Reviews · doi:10.1002/med.10021 · Cited by 214
Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer
Kröger, N., Kleeberg, U. R., Mross, K., Edler, L., & Hossfeld, D. K. (2000) · Oncology Research and Treatment · doi:10.1159/000027075 · Cited by 209
Spingler, B., Whittington, D. A., & Lippard, S. J. (2001) · Inorganic Chemistry · doi:10.1021/ic010790t · Cited by 207
Bypass of DNA Lesions Generated During Anticancer Treatment with Cisplatin by DNA Polymerase η
Alt, A., Lammens, K., Chiocchini, C., Lammens, A., Pieck, J. C., Kuch, D., Hopfner, K.-P., & Carell, T. (2007) · Science · doi:10.1126/science.1148242 · Cited by 203
Metal ions, Alzheimer's disease and chelation therapy
Budimir, A. (2011) · Acta Pharmaceutica · doi:10.2478/v10007-011-0006-6 · Cited by 202
Targeting Large Kinase Active Site with Rigid, Bulky Octahedral Ruthenium Complexes
Maksimoska, J., Feng, L., Harms, K., Yi, C., Kissil, J., Marmorstein, R., & Meggers, E. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805555a · Cited by 200
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
Kapitza, S., Pongratz, M., Jakupec, M. A., Heffeter, P., Berger, W., Lackinger, L., Keppler, B. K., & Marian, B. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0617-0 · Cited by 200
Coste, F., Malinge, J.-M., Serre, L., Leng, M., Zelwer, C., Shepard, W., & Roth, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.8.1837 · Cited by 199
Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds
Casini, A., & Messori, L. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611798040732 · Cited by 196
Biot, C., Taramelli, D., Forfar-Bares, I., Maciejewski, L. A., Boyce, M., Nowogrocki, G., Brocard, J. S., Basilico, N., Olliaro, P., & Egan, T. J. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500061 · Cited by 192
Betanzos‐Lara, S., Liu, Z., Habtemariam, A., Pizarro, A. M., Qamar, B., & Sadler, P. J. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201108175 · Cited by 189
Self-citationBranco, V., Canário, J., Lu, J., Holmgren, A., & Carvalho, C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.12.002 · Cited by 186
Chromium: celebrating 50 years as an essential element?
Vincent, J. B. (2010) · Dalton Transactions · doi:10.1039/b920480f · Cited by 184
Wai-Yin Sun, R., Lok-Fung Chow, A., Li, X.-H., Yan, J. J., Sin-Yin Chui, S., & Che, C.-M. (2011) · Chemical Science · doi:10.1039/c0sc00593b · Cited by 181
Photocontrolled DNA Binding of a Receptor-Targeted Organometallic Ruthenium(II) Complex
Barragán, F., López-Senín, P., Salassa, L., Betanzos-Lara, S., Habtemariam, A., Moreno, V., Sadler, P. J., & Marchán, V. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205235m · Cited by 180
Self-citationThe antimalarial ferroquine: from bench to clinic
Biot, C., Nosten, F., Fraisse, L., Ter-Minassian, D., Khalife, J., & Dive, D. (2011) · Parasite · doi:10.1051/parasite/2011183207 · Cited by 180
A Third Mode of DNA Binding: Phosphate Clamps by a Polynuclear Platinum Complex
Komeda, S., Moulaei, T., Woods, K. K., Chikuma, M., Farrell, N. P., & Williams, L. D. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062851y · Cited by 178
A Ruthenium Antimetastasis Agent Forms Specific Histone Protein Adducts in the Nucleosome Core
Wu, B., Ong, M. S., Groessl, M., Adhireksan, Z., Hartinger, C. G., Dyson, P. J., & Davey, C. A. (2011) · Chemistry – A European Journal · doi:10.1002/chem.201100298 · Cited by 174
Sannella, A. R., Casini, A., Gabbiani, C., Messori, L., Bilia, A. R., Vincieri, F. F., Majori, G., & Severini, C. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.028 · Cited by 172
Mechanism of transcriptional stalling at cisplatin-damaged DNA
Damsma, G. E., Alt, A., Brueckner, F., Carell, T., & Cramer, P. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1314 · Cited by 171
Wang, F., Xu, J., Habtemariam, A., Bella, J., & Sadler, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053387k · Cited by 169
Self-citationIridium Complex with Antiangiogenic Properties
Wilbuer, A., Vlecken, D. H., Schmitz, D. J., Kräling, K., Harms, K., Bagowski, C. P., & Meggers, E. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000682 · Cited by 168
Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian Cancer
Madhusudan, S., Muthuramalingam, S. R., Braybrooke, J. P., Wilner, S., Kaur, K., Han, C., Hoare, S., Balkwill, F., & Ganesan, T. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.127 · Cited by 167
Nitric oxide NO - biogeneration regulation and relevence to human diseases
Bian, K. (2003) · Frontiers in Bioscience · doi:10.2741/997 · Cited by 164
A Metal‐Based Inhibitor of Tumor Necrosis Factor‐α
Leung, C., Zhong, H., Yang, H., Cheng, Z., Chan, D. S., Ma, V. P., Abagyan, R., Wong, C., & Ma, D. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202937 · Cited by 164
Wu, P., Ma, D., Leung, C., Yan, S., Zhu, N., Abagyan, R., & Che, C. (2009) · Chemistry – A European Journal · doi:10.1002/chem.200901943 · Cited by 161
From Conventional to Unusual Enzyme Inhibitor Scaffolds: The Quest for Target Specificity
Meggers, E. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201005673 · Cited by 158
A Peptide Molecule Mimicking the Copper(II) Transport Site of Human Serum Albumin
Lau, S.-J., Kruck, T. P. A., & Sarkar, B. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79900-x · Cited by 153
Alzheimer's disease & metals: therapeutic opportunities
Kenche, V. B., & Barnham, K. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01221.x · Cited by 149
Stable Anticancer Gold(III)–Porphyrin Complexes: Effects of Porphyrin Structure
Sun, R. W., Li, C. K.-L., Ma, D., Yan, J. J., Lok, C., Leung, C., Zhu, N., & Che, C. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200902741 · Cited by 149
Delangle, P., & Mintz, E. (2012) · Dalton Transactions · doi:10.1039/c2dt12188c · Cited by 146
Selenium‐containing amino acids as direct and indirect antioxidants
Rahmanto, A. S., & Davies, M. J. (2012) · IUBMB Life · doi:10.1002/iub.1084 · Cited by 144
van Rijt, S., Mukherjee, A., Pizarro, A. M., & Sadler, P. J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901556u · Cited by 142
Self-citationDiversity in Guanine‐Selective DNA Binding Modes for an Organometallic Ruthenium Arene Complex
Liu, H., Berners‐Price, S. J., Wang, F., Parkinson, J. A., Xu, J., Bella, J., & Sadler, P. J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602873 · Cited by 142
Self-citationA Metal‐Based Inhibitor of Tumor Necrosis Factor‐α
Leung, C., Zhong, H., Yang, H., Cheng, Z., Chan, D. S., Ma, V. P., Abagyan, R. A., Wong, C., & Ma, D. (2012) · Angewandte Chemie · doi:10.1002/ange.201202937 · Cited by 142
Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A
Vacca, A., Bruno, M., Boccarelli, A., Coluccia, M., Ribatti, D., Bergamo, A., Garbisa, S., Sartor, L., & Sava, G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600176 · Cited by 140
Potent Estrogenic Agonists Bearing Dicarba-closo-dodecaborane as a Hydrophobic Pharmacophore
Endo, Y., Iijima, T., Yamakoshi, Y., Yamaguchi, M., Fukasawa, H., & Shudo, K. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9900725 · Cited by 140
Elemental composition of secretory granules in pancreatic islets of Langerhans
Foster, M. C., Leapman, R. D., Li, M. X., & Atwater, I. J. (1993) · Biophysical Journal · doi:10.1016/s0006-3495(93)81397-3 · Cited by 138
Design of iron chelators with therapeutic application
Zhou, T., Ma, Y., Kong, X., & Hider, R. C. (2012) · Dalton Transactions · doi:10.1039/c2dt12159j · Cited by 136
PIM1 kinase as a target for cancer therapy
Merkel, A. L., Meggers, E., & Ocker, M. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.668527 · Cited by 133
Liang, X., Parkinson, J. A., Weishäupl, M., Gould, R. O., Paisey, S. J., Park, H.-S., Hunter, T. M., Blindauer, C. A., Parsons, S., & Sadler, P. J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0260723 · Cited by 132
Self-citationOrganometallic Osmium Arene Complexes with Potent Cancer Cell Cytotoxicity
Fu, Y., Habtemariam, A., Pizarro, A. M., van Rijt, S., Healey, D. J., Cooper, P. A., Shnyder, S. D., Clarkson, G. J., & Sadler, P. J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100560f · Cited by 132
Self-citationTucker, H., Crook, J. W., & Chesterson, G. J. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00400a011 · Cited by 130
Barry, N. P. E., & Sadler, P. J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15300a · Cited by 129
Self-citationTherapeutic Redistribution of Metal Ions To Treat Alzheimer’s Disease
Crouch, P. J., & Barnham, K. J. (2012) · Accounts of Chemical Research · doi:10.1021/ar300074t · Cited by 128
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Sun, R. C., Philip G. Board, & Blackburn, A. C. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-142 · Cited by 127
Bioinorganic and medicinal chemistry: aspects of gold(i)-protein complexes
Bhabak, K. P., Bhuyan, B. J., & Mugesh, G. (2011) · Dalton Transactions · doi:10.1039/c0dt01057j · Cited by 127
Evidence for Drug Release from a Metalla‐Cage Delivery Vector Following Cellular Internalisation
Zava, O., Mattsson, J., Therrien, B., & Dyson, P. J. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200903216 · Cited by 127
Clercq, E. D. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.009 · Cited by 125
Investigation of the Redox Behavior of Ferroquine, a New Antimalarial
Leleu‐Chavain, N., Vezin, H., Dive, D., Touati, N., Paul, J., Buisine, E., & Biot, C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800007x · Cited by 124
Tryptophan Switch for a Photoactivated Platinum Anticancer Complex
Butler, J. S., Woods, J. A., Farrer, N. J., Newton, M. E., & Sadler, P. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3074159 · Cited by 120
Self-citationNanostructures as Promising Tools for Delivery of Antimicrobial Peptides
Brandelli, A. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712801264774 · Cited by 120
Miederer, M., McDevitt, M. R., Sgouros, G., Kramer, K., Cheung, N. V., & Scheinberg, D. A. (2004) · PubMed · Cited by 119
Pratesi, G., Perego, P., Polizzi, D., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690620 · Cited by 118
Ruthenium(II) Arene Anticancer Complexes with Redox-Active Diamine Ligands
Bugarcic, T., Habtemariam, A., Deeth, R. J., Fabbiani, F. P. A., Parsons, S., & Sadler, P. J. (2009) · Inorganic Chemistry · doi:10.1021/ic9013366 · Cited by 117
Self-citationSun, D., Liu, Y., Liu, D., Zhang, R., Yang, X., & Liu, J. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201103156 · Cited by 116
Marzilli, L. G., Saad, J. S., Kuklenyik, Z., Keating, K. A., & Xu, Y. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0007915 · Cited by 113
Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe
Yang, N., Zhang, H., Wang, M., Hao, Q., & Sun, H. (2012) · Scientific Reports · doi:10.1038/srep00999 · Cited by 113
Organometallic Osmium(II) Arene Anticancer Complexes Containing Picolinate Derivatives
van Rijt, S., Peacock, A. F. A., Johnstone, R. D. L., Parsons, S., & Sadler, P. J. (2009) · Inorganic Chemistry · doi:10.1021/ic8020222 · Cited by 112
Self-citationWerner coordination chemistry and neurodegeneration
Telpoukhovskaia, M. A., & Orvig, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35236b · Cited by 112
Todd, R. C., & Lippard, S. J. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.04.005 · Cited by 111
Prast‐Nielsen, S., Cebula, M., Pader, I., & Arnér, E. S. J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.008 · Cited by 111
Tracking Bismuth Antiulcer Drug Uptake in Single Helicobacter pylori Cells
Tsang, C., Ho, K.-S., Sun, H., & Chan, W.-T. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2013278 · Cited by 111
Excursions in polynuclear platinum DNA binding
Mangrum, J. B., & Farrell, N. P. (2010) · Chemical Communications · doi:10.1039/c0cc01254h · Cited by 110
Yan, K., Lok, C., Bierła, K., & Che, C. (2010) · Chemical Communications · doi:10.1039/c0cc01058h · Cited by 110
Kastl, A., Wilbuer, A., Merkel, A. L., Feng, L., Fazio, P. D., Ocker, M., & Meggers, E. (2011) · Chemical Communications · doi:10.1039/c1cc15378a · Cited by 110
Faller, P., & Hureau, C. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201202697 · Cited by 109
Farrell, N. P., Appleton, T. G., Qu, Y., Roberts, J. D., Fontes, A. P. S., Skov, K. A., Wu, P., & Zou, Y. (1995) · Biochemistry · doi:10.1021/bi00047a013 · Cited by 108
Baruah, H., Barry, C. G., & Bierbach, U. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387313 · Cited by 108
Groessl, M., Tsybin, Y. O., Hartinger, C. G., Keppler, B. K., & Dyson, P. J. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-010-0635-0 · Cited by 106
Suntharalingam, K., White, A. J. P., & Vilar, R. (2010) · Inorganic Chemistry · doi:10.1021/ic100884p · Cited by 104
Fu, Y., Romero, M. J., Habtemariam, A., Snowden, M. E., Song, L., Clarkson, G. J., Qamar, B., Pizarro, A. M., Unwin, P. R., & Sadler, P. J. (2012) · Chemical Science · doi:10.1039/c2sc20220d · Cited by 101
Self-citationPhosphine-Gold(I) Compounds as Anticancer Agents: General Description and Mechanisms of Action
Lima, J. C., & Rodríguez, L. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011797927670 · Cited by 101
Khan, H., Badshah, A., Murtaz, G., Said, M., Rehman, Z., Neuhausen, C., Todorova, M. I., Jean‐Claude, B. J., & Butler, I. S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.06.007 · Cited by 99
DeCensi, A., Boccardo, F., Guarneri, D., Positano, N., Paoletti, M. C., Costantini, M., Martorana, G. E., Giuliani, L., & The Italian Prostatic Cancer Project S0022534717377996-022ac75b10cf8560b3ba2734044b0168 C.P. Baccarani, S.-5. E. B. (1991) · The Journal of Urology · doi:10.1016/s0022-5347(17)37799-6 · Cited by 98
Sava, G., Jaouen, G., Hillard, E. A., & Bergamo, A. (2012) · Dalton Transactions · doi:10.1039/c2dt30075c · Cited by 97
Crystal Structure of the PIM2 Kinase in Complex with an Organoruthenium Inhibitor
Bullock, A. N., Russo, S., Amos, A. L., Pagano, N., Bregman, H. S., Debreczeni, J. E., Lee, W. H., von Delft, F., Meggers, E., & Knapp, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007112 · Cited by 96
Wu, H., Yuan, J., Bai, Y., Pan, G., Wang, H., Kong, J., Fan, X., & Liu, H. (2012) · Dalton Transactions · doi:10.1039/c2dt30512g · Cited by 95
Polypyridyl Metal Complexes with Biological Activity
Salassa, L. (2011) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201100376 · Cited by 95
Ramakrishnan, S., Suresh, E., Riyasdeen, A., Akbarsha, M. A., & Palaniandavar, M. (2011) · Dalton Transactions · doi:10.1039/c0dt01360a · Cited by 95
The thiol‐based redox networks of pathogens: Unexploited targets in the search for new drugs
Jaeger, T., & Flohé, L. (2006) · BioFactors · doi:10.1002/biof.5520270110 · Cited by 94
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
Morbidelli, L., Donnini, S., Filippi, S., Luigi Messori, A., Piccioli, F., Orioli, P., Sava, G., & Ziche, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600906 · Cited by 92
Arsenic-Based Antineoplastic Drugs and Their Mechanisms of Action
Ralph, S. J. (2008) · Metal-Based Drugs · doi:10.1155/2008/260146 · Cited by 91
Inhibition of phosphatase and sulfatase by transition-state analogs
Stankiewicz, P. J., & Gresser, M. J. (1988) · Biochemistry · doi:10.1021/bi00401a031 · Cited by 91
Anderson, H. D., Wagstaff, J. D., Crowther, D., Swindell, R., Lind, M., McGregor, J., Timms, M. S., Brown, D., & Palmer, P. A. (1988) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(88)90338-0 · Cited by 91
Pitto‐Barry, A., Barry, N. P. E., Zava, O., Deschenaux, R., Dyson, P. J., & Therrien, B. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201002634 · Cited by 91
Self-citationCasini, A., Guerri, A., Gabbiani, C., & Luigi Messori, A. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.12.022 · Cited by 90
Similar Biological Activities of Two Isostructural Ruthenium and Osmium Complexes
Maksimoska, J., Williams, D. S., Atilla‐Gokcumen, G. E., Smalley, K. S. M., Carroll, P. J., Webster, R. D., Filippakopoulos, P., Knapp, S., Herlyn, M., & Meggers, E. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200800294 · Cited by 89
Yang, X., Palanichamy, K., Ontko, A. C., Rao, M. N. A., Fang, C. X., Ren, J. T., & Sreejayan, N. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.049 · Cited by 87
Westendorf, A. F., Woods, J. A., Korpis, K., Farrer, N. J., Salassa, L., Robinson, K. S., Appleyard, V. C. L., Murray, K. E., Grünert, R., Thompson, A. M., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0959 · Cited by 87
Self-citationBaruah, H., Wright, M. W., & Bierbach, U. (2005) · Biochemistry · doi:10.1021/bi050021b · Cited by 85
Yu, S., Girotto, S., Lee, C., & Magliozzo, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300326200 · Cited by 84
Anti-TNF-α Antibody Therapies in Autoimmune Diseases
Chatzantoni, K., & Mouzaki, Α. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606778194217 · Cited by 83
Improvement of porphyrins for G-quadruplex DNA targeting
Romera, C., Bombarde, O., Bonnet, R., Gómez, D., Dumy, P., Calsou, P., Gwan, J.-F., Lin, J., Defrancq, É., & Pratviel, G. (2011) · Biochimie · doi:10.1016/j.biochi.2011.06.008 · Cited by 83
The antimicrobial properties of some copper( ii ) and platinum( ii ) 1,10-phenanthroline complexes
Ng, N. S., Leverett, P., Hibbs, D. E., Yang, Q., Bulanadi, J. C., Wu, M. J., & Aldrich-Wright, J. R. (2012) · Dalton Transactions · doi:10.1039/c2dt32392c · Cited by 82
Evidence for albumin – Cu(II) – amino acid ternary complex
Sarkar, B., & Wigfield, Y. Y. (1968) · Canadian Journal of Biochemistry · doi:10.1139/o68-092 · Cited by 82
Anticancer activity of opened arene ruthenium metalla-assemblies
Barry, N. P. E., Zava, O., Furrer, J., Dyson, P. J., & Therrien, B. (2010) · Dalton Transactions · doi:10.1039/c001521k · Cited by 82
Self-citationFu, Y., Habtemariam, A., Basri, A. M., Braddick, D., Clarkson, G. J., & Sadler, P. J. (2011) · Dalton Transactions · doi:10.1039/c1dt10937e · Cited by 79
Self-citationBourgeois, M., Rajérison, H., Guérard, F., Mougin‐Degraef, M., Barbet, J., Michel, N., Chérel, M., & Faivre-Chauvet, A. (2011) · Nuclear Medicine Review · doi:10.5603/nmr.2011.00022 · Cited by 78
Manikandamathavan, V. M., Rajapandian, V., Freddy, A. J., Weyhermüller, T., Subramanian, V., & Nair, B. U. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.039 · Cited by 77
Synthesis and Structure Activity Relationship of Organometallic Steroidal Androgen Derivatives
Top, S., Thibaudeau, C., Vessières, A., Brûlé, E., Bideau, F. L., Joerger, J., Plamont, M., Samreth, S., Edgar, A., Marrot, J., et al. (2009) · Organometallics · doi:10.1021/om800698y · Cited by 76
Anti-androgenicity of flutamide and its metabolite Sch 16423.
NERI, R., PEETS, E., & WATNICK, A. (1979) · Biochemical Society Transactions · doi:10.1042/bst0070565 · Cited by 72
Anti-colorectal cancer activity of an organometallic osmium arene azopyridine complex
Shnyder, S. D., Fu, Y., Habtemariam, A., van Rijt, S., Cooper, P. A., Loadman, P. M., & Sadler, P. J. (2011) · MedChemComm · doi:10.1039/c1md00075f · Cited by 69
Self-citationMarquele‐Oliveira, F., de Santana, D. C. A. S., Taveira, S. F., Vermeulen, D. M., de Oliveira, A. R. M., da Silva, R. S., & Lopez, R. F. V. (2010) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2010.06.007 · Cited by 68
Investigation of the Reactivity between a Ruthenium Hexacationic Prism and Biological Ligands
Paul, L. E. H., Therrien, B., & Furrer, J. (2011) · Inorganic Chemistry · doi:10.1021/ic2021935 · Cited by 68
Effects of chromium picolinate on body composition.
Trent, L. K., & Thieding-Cancel, D. (1995) · PubMed · Cited by 67
Insulin-sensitizing and cholesterol-lowering effects of chromium (d-Phenylalanine)3
Yang, X., Li, S., Dong, F., Ren, J. T., & Sreejayan, N. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.01.039 · Cited by 67
NMR Solution Structure of an Oxaliplatin 1,2-d(GG) Intrastrand Cross-link in a DNA Dodecamer Duplex
Wu, Y., Pradhan, P., Havener, J. M., Boysen, G., Swenberg, J. A., Campbell, S. L., & Chaney, S. G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.066 · Cited by 66
Biot, C., Leleu‐Chavain, N., Dubar, F., Pradines, B., Trivelli, X., Brocard, J. S., Forfar, I., & Dive, D. (2008) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2008.09.033 · Cited by 66
Pitto‐Barry, A., Barry, N. P. E., Zava, O., Deschenaux, R., & Therrien, B. (2011) · Chemistry - An Asian Journal · doi:10.1002/asia.201100136 · Cited by 65
Self-citationWilson, T., Williamson, M. P., & Thomas, J. A. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/b924263e · Cited by 63
Discovery of a strongly apoptotic ruthenium complex through combinatorial coordination chemistry
Mulcahy, S. P., Gründler, K., Frias, C., Wagner, L., Prokop, A., & Meggers, E. (2010) · Dalton Transactions · doi:10.1039/c0dt00034e · Cited by 63
Romero‐Canelón, I., Pizarro, A. M., Habtemariam, A., & Sadler, P. J. (2012) · Metallomics · doi:10.1039/c2mt20189e · Cited by 62
Self-citationKawasuji, T., Johns, B. A., Yoshida, H., Taishi, T., Taoda, Y., Murai, H., Kiyama, R., Fuji, M., Yoshinaga, T., Seki, T., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3010459 · Cited by 61
Competitive Binding of Bismuth to Transferrin and Albumin in Aqueous Solution and in Blood Plasma
Sun, H., Li, H., Mason, A. B., Woodworth, R. C., & Sadler, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004779200 · Cited by 61
Self-citationGarderen, C. J. V., & Houte, L. P. A. V. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.1169b.x · Cited by 58
Król, E., & Krejpcio, Z. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.07.008 · Cited by 57
Probing chelation motifs in HIV integrase inhibitors
Agrawal, A., DeSoto, J., Fullagar, J. L., Maddali, K., Rostami, S., Richman, D. D., Pommier, Y. G., & Cohen, S. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112389109 · Cited by 57
Cited by
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Classification of Metal-Based Drugs according to Their Mechanisms of Action
Boros, E., Dyson, P. J., & Gasser, G. (2020) · Chem · doi:10.1016/j.chempr.2019.10.013 · Cited by 437
Lazarević, T., Rilak, A., & Bugarčić, Ž. D. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.007 · Cited by 428
Carbon monoxide – physiology, detection and controlled release
Heinemann, S. H., Hoshi, T., Westerhausen, M., & Schiller, A. (2014) · Chem. Commun. · doi:10.1039/c3cc49196j · Cited by 388
Metadata
- Authors
- Barry, N. P. E., & Sadler, P. J.
- Venue
- Chemical Communications
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 49
- Issue
- 45
- Pages
- 5106
- ISSN
- 1359-7345 (ISSN-L)
- 1364-548X
- OpenAlex
- W2130237005
- Cited by
- 717
- References
- 243
- FWCI
- 35.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.